JG

Jerry Gomez

Director Of Market Access And Reimbursement at CeQur

Jerry Gomez has a diverse work experience that spans over several sectors. Jerry currently holds the position of Director of Market Access and Reimbursement at CeQur, where they are responsible for establishing and building relationships with key National Payers to support the commercialization of a wearable insulin delivery system. Prior to this, Jerry worked at ArkrayUSA USM Division as the Director of the Managed Care Division, where they led the team in branding, promoting, and contracting for consumer health product lines within the diabetes category. Jerry also served as the National Managed Care Specialist, accountable for customer relationships and contracting efforts with various healthcare organizations. Before their time at ArkrayUSA, Jerry was the Senior Director of Business Development and Payor Relations at Calloway Labs, Inc., responsible for account management and contracting for lab services. Jerry also held the position of Vice President of Strategic Markets at MCT Synergistics. Earlier in their career, Jerry worked at King Pharmaceuticals in various roles, including Director of Corporate Accounts and Manager of Operations - Sales Planning. Jerry started their professional journey at Visual Enterprises, Inc. as the General Manager/Account Executive. Jerry's work experience also includes roles at Farmers Insurance and another stint at Visual Enterprises, Inc. where they served as a bookkeeper and sales manager. Throughout their career, Jerry has demonstrated exceptional skills in market access, managed care, sales, and business development.

Jerry Gomez earned a Bachelor of Business Administration (BBA) degree, with a focus on Marketing, from UTEP in 1993. Jerry then pursued further education and obtained a Master of Business Administration (MBA) degree with a specialization in International Business from UTEP in 2004.

Links

Previous companies

Farmers Insurance logo
ARKRAY USA logo

Timeline

  • Director Of Market Access And Reimbursement

    December, 2021 - present